OneSource Specialty Pharma Limited

NSEI:ONESOURCE Stock Report

Market Cap: ₹181.0b

OneSource Specialty Pharma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Neeraj Sharma

Chief executive officer

₹2.7m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure1.3yrs

Recent management updates

No updates

Recent updates

CEO

Neeraj Sharma (52 yo)

less than a year

Tenure

₹2,670,000

Compensation

Mr. Neeraj Sharma is Managing Director and Director of OneSource Specialty Pharma Limited (Formerly Stelis Biopharma Limited) since March 01, 2024 He serves as an Independent Non-Executive Director of Fagr...

Leadership Team

NamePositionTenureCompensationOwnership
Neeraj Sharma
MD & Directorless than a year₹2.67mno data
Trisha A
Company Secretary & Compliance officerless than a year₹1.64mno data
Anurag Bhagania
Chief Financial Officerless than a yearno datano data
Biju Mathew
Chief Operating Officer1yrno datano data
Murari Mishra
Chief Human Resources Officerno datano datano data
Prateek Gupta
SVP & Head of Technical Developmentno datano datano data
Milan Doshi
Senior Vice President of Global BDno datano datano data
Ravi Kumar
Head of Corporate Strategy & Operational Excellenceno datano datano data

0.7yrs

Average Tenure

Experienced Management: ONESOURCE's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Neeraj Sharma
MD & Directorless than a year₹2.67mno data
Gopakumar Nair
Non Executive Independent Director1.7yrs₹3.60mno data
Raghavan Varadarajan
Member of Scientific Advisory Boardno datano datano data
P. Rangarajan
Member of Scientific Advisory Boardno datano datano data
Bharat Shah
Non-Executive Non-Independent Directorless than a yearno datano data
Rajashri Santosh Ojha
Non Executive Independent Director1.7yrs₹3.20mno data

1.3yrs

Average Tenure

66yo

Average Age

Experienced Board: ONESOURCE's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 14:39
End of Day Share Price 2025/01/31 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OneSource Specialty Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution